首页> 外文期刊>BMC Nephrology >Suboptimal medical care of patients with ST-Elevation Myocardial Infarction and Renal Insufficiency: results from the Korea acute Myocardial Infarction Registry
【24h】

Suboptimal medical care of patients with ST-Elevation Myocardial Infarction and Renal Insufficiency: results from the Korea acute Myocardial Infarction Registry

机译:ST抬高型心肌梗死和肾功能不全患者的次优医疗:韩国急性心肌梗死注册中心的结果

获取原文
           

摘要

Background The clinical outcomes of ST-segment elevation myocardial infarction (STEMI) are poor in patients with renal insufficiency. This study investigated changes in the likelihood that patients received optimal medical care throughout the entire process of myocardial infarction management, on the basis of their glomerular filtration rate (GFR). Methods This study analyzed 7,679 patients (age, 63?±?13?years; men 73.6%) who had STEMI and were enrolled in the Korea Acute Myocardial Infarction Registry (KAMIR) from November 2005 to August 2008. The study subjects were divided into 5 groups corresponding to strata used to define chronic kidney disease stages. Results Patients with lower GFR were less likely to present with typical chest pain. The average symptom-to-door time, door-to-balloon time, and symptom-to-balloon time were longer with lower GFR than higher GFR. Primary reperfusion therapy was performed less frequently and the results of reperfusion therapy were poorer in patients with renal insufficiency; these patients were less likely to receive adjunctive medical treatment, such as treatment with aspirin, clopidogrel, β-blocker, angiotensin-converting enzyme (ACE) inhibitor/angiotensin-receptor blocker (ARB), or statin, during hospitalization and at discharge. Patients who received less intense medical therapy had worse clinical outcomes than those who received more intense medical therapy. Conclusions Patients with STEMI and renal insufficiency had less chance of receiving optimal medical care throughout the entire process of MI management, which may contribute to worse outcomes in these patients.
机译:背景技术肾功能不全的患者ST段抬高型心肌梗死(STEMI)的临床结局较差。这项研究根据其肾小球滤过率(GFR),调查了患者在整个心肌梗塞处理过程中获得最佳医疗护理的可能性的变化。方法这项研究分析了2005年11月至2008年8月在韩国急性心肌梗死登记处(KAMIR)入组的7679例STEMI患者(年龄63岁±13岁;男性73.6%)。对应于地层的5组用于定义慢性肾脏疾病阶段。结果GFR较低的患者较少出现典型的胸痛。 GFR较低者的平均症状到门时间,上气球时间和症状到气球的时间长于GFR较高者。肾功能不全患者初次再灌注治疗的频率较低,再灌注结果较差;这些患者在住院期间和出院时不太可能接受辅助治疗,例如使用阿司匹林,氯吡格雷,β受体阻滞剂,血管紧张素转化酶(ACE)抑制剂/血管紧张素受体阻滞剂(ARB)或他汀类药物。接受较少强度药物治疗的患者的临床结局要比接受较高强度药物治疗的患者差。结论STEMI和肾功能不全的患者在MI管理的整个过程中获得最佳医疗护理的机会较小,这可能导致这些患者的预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号